Aseptic Loosening of Total Hip Implant: Mechanisms of Osteolysis and Potential Therapy



Cite item

Full Text

References

  1. Родионова С.С., Нуждин В.И., Морозов А.К. и др. Остеопороз как фактор риска асептической нестабильности при эндопротезировании тазобедренного сустава //Вестн. травматол. ортопед. - 2007. - N 2. - С. 35-40.
  2. Тургумбаев Т.Н. Изучение влияния алендроната на формирование вторичной стабильности эндопротеза тазобедренного сустава: Автореф.: дис. ... канд. мед. наук. - М., 2010.
  3. Шерепо К.М. Износ головок тотальных эндопротезов тазобедренного сустава //Ортопед. травматол. - 1988. - N 6. - С. 25-27.
  4. Ambruzova Z., Gallo J., Mrazek. et al. Association of cytokine gene polymorphisms with the expansive periprosthetic osteolysis in total hip arthroplasty //Tissue Antigens. - 2006. - Vol. 67, N 1. - P. 178-183.
  5. Antoniou J., Huk O., Zukor D. et al. Collagen crosslinked N-telopeptides as markers for evaluating particulate osteolysis: a preliminary study //J. Orthop. Res. - 2000. -Vol. 18, N 1. - P. 64-67.
  6. Aspenberg P., Van der Vis H. Fluid pressure may cause periprosthetic osteolysis. Particles are not the only thing //Acta Orthop. Scand. - 1998. - Vol. 69, N 1. - P. 1-4.
  7. Bauer T.W. Particles and periimplant bone resorption //Clin. Orthop. - 2002. - N 405. - P. 138-143.
  8. Bhandari M., Bajammal S., Guyatt G.H. et al. Effect of bisphosphinates on periprosthetic bone loss after total joint arthroplasty. A meta-analysis //J. Bone Jt Surg. - 2005. - Vol. 87A, N 3. - P. 293-301.
  9. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation //Nature. - 2003. - Vol. 423, N 3. - P. 337-342.
  10. Capparelli C., Morony S., Warmington K. et al. Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmokinetic analysis in rats //J. Bone Miner. Res. - 2003. - Vol. 18, N 4. - P. 852-958.
  11. Claus L.M., Engh C.A., Sychterz C.J. et al. Radiographic definition of pelvic osteolysis following total hip arthroplasty //J. Bone Jt Surg. - 2003. - Vol. 85A, N 8. - P. 1519-1526.
  12. Fender D., Harper W.M., Gregg P.J. Outcome of Charnley total hip replacement across a single health region in England: the results at five years from a regional hip register //J. Bone Jt Surg. - 1999. - Vol. 81B, N 3. - P. 577-581.
  13. Gallo J., Harvanek V., Zapletalova J., Cechova I. Influence of demographic, surgical and implant variables on wear rate and osteolysis in ABG I hip arthroplasty //Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Republic. - 2006. - Vol. 150, N 1. - P. 135-141.
  14. Gonzalez O., Smith R.L., Goodman S.B. Effect of size, concentration surface area and volume of polymethylmethacrylate particles on human macrophages in vitro //J. Biomed. Mater. Res. - 1996. - Vol. 30, N 3. - P. 463-473.
  15. Goodman S.B., Chin R.C., Chiou S.S. et. al. A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total arthroplasties //Clin. Orthop. - 1989. - N 244. - P. 182-187.
  16. Goodman S.B. The effects of micromotion and particulate materials on tissue differentiation. Bone chamber studies in rabbits //Acta Orthop. Scand. - 1994. - Vol. 65, Suppl. 258. - P. 1-43.
  17. Goodman S.B., Trindade M., Ma T. et al. Pharmacologic modulation of periprosthetic osteolysis //Clin. Orthop. - 2005. - N 430. - P. 39-45.
  18. Green T.R., Fisher J., Matthews J.B. et al. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles //J. Biomed. Mater. Res. - 2000. - Vol. 53, N 5. - P. 490-497.
  19. Hallab N.J., Anderson S., Stafford T. et al. Lymphocyte responses in patients with total hip arthroplasty //J. Orthop. Res. - 2005. - Vol. 23, N 2. - P. 384-391.
  20. Hanssen A.D., Rand J.A. A comparison of primary and revision total knee arthroplasty using the kinematic stabilizer prosthesis //J. Bone Jt Surg. - 1988. - Vol. 70A, N 3. - P. 491-499.
  21. Harris W.H. Osteolysis and particles disease in hip replacement. A review //Acta Orthop. Scand. - 1994. - Vol. 65, N 1. - P. 113-123.
  22. Holding C.A., Findlay D.M., Stamenkov R. et al. The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants //Biomaterials. - 2006. - Vol. 27, N 2. - P. 212-219.
  23. Holstead J., Kong Y.Y., Renninger J.M. Role of RANKL and RANK in bone loss and arthritis //Ann. Rheumat. Dis. - 2002. - Vol. 61, N 1. - P. 32-39.
  24. Horowitz S.M., Gautsch T.L., Frondoza C.G., Riley L. Macrophage exposure to polymethylmethacrylate leads to mediator release and injury //J. Orthop. Res. - 1991. - Vol. 9, N 3. - P. 406-413.
  25. Horowitz S.M., Doty S.B., Lane J.M., Burstein A.H. Studies of the mechanism by which the mechanical failure of polymethylmetacrylate leads to bone resorption //J. Bone Jt Surg. - 1993. - Vol. 75A, N 4. - P. 802-813.
  26. Huiskes R. Stress shielding and bone resorption in THA: clinical versus computer-simulation studies. //Acta Orthop. Belg. - 1993. - Vol. 59, Suppl. 1. - P. 1-17.
  27. Hundric-Haspl Z., Pecina M., Naspl M. et al. Plasma cytokines as markers of aseptic prosthesis loosening //Clin. Orthop. - 2006. - N 453. - P. 299-304.
  28. Jasty M.J., Floyd W.E., Schiller A.L. et al. Localized osteolysis in stable, non-septic total hip replacement //J. Bone Jt Surg. - 1986. - Vol. 68A, N 4. - P. 912-919.
  29. Kadoya Y., Kobayashi A., Ohashi H. Wear and osteolysis in total joint replacements //Acta Orthop. Scand. - 1995. - Vol. 69, N 1. - P. 1-16.
  30. Karrholm J., Borssen B., Lowenhielm G. et al. Does early micromotion of femoral stem prostheses matter? 4-7 year stereoradiographic follow-up of 84 cemented prostheses //J. Bone Jt Surg. - 1994. - Vol. 76A, N 4. - P. 912-917.
  31. Kim Y.H., Kim J.S., Cho S.H. Primary total hip arthroplasty with a cementless porous-coated anatomic total hip prosthesis: 10- to 12-year results of prospective and consecutive series //J. Arthroplasty. - 1999. - Vol. 14, N 3. - P. 538-548.
  32. Kinov P., Tivchev P., Doukova P., Leithner A. Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomized study //Acta Orthop. Belg. - 2006. - Vol. 72, N 1. - P. 44-50.
  33. Kottinen Y.T., Zhao D.Z., Beklen A. THR microenvironment //Clin. Orthop. - 2005. - N 430. - P. 28-38.
  34. Lacey D.L., Timms E., Tan H.L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation //Cell. - 1998. - Vol. 93, N 1. - P. 165-176.
  35. Lam J., Abu-Amer Y., Nelson C. et al. Tumor necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis //Ann. Rheum. Dis. - 2002. - Vol. 61, N 1. - P. 82-83.
  36. Ma G., Ainola M., Liljestrom M. et al. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip-replacement implants //J. Rheumatol. - 2005. - Vol. 32, N 9. - P. 1943-1950.
  37. Malik M.H., Bayat A., Juri F. et al. Genetic susceptibility to hip arthroplasty failure - association with the RANK/OPG pathway //Int. Orthop. - 2006. - Vol. 30, N 1. - P. 177-181.
  38. Maloney W., Smith R. Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris //J. Bone Jt Surg. - 1995. - Vol. 77A, N 7. - P. 1448-1461.
  39. Mandelin J., Li T.-F., Liljestrom M. et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement //J. Bone Jt Surg. - 2003. - Vol. 85B, N 8. - P. 1196-1201.
  40. Margevicius K.J., Bauer T.W., McMahon J.T. et al. Isolation and characterization of debris in membranes around total joint prosthesis //J. Bone Jt Surg. - 1994. - Vol. 76A, N 10. - P. 1664-1675.
  41. Martin T.J., Sims N.A. Osteoblast-derived activity in the coupling of bone formation to resorption //Trends Mol. Med. - 2005. - Vol. 11, N 1. - P. 76-81.
  42. Matthews J.B., Green T.R., Stone M.H. et al. Comparison of the response of primary human peripheral blood mononuclear phagocytes from different donors to challenge with model polyethylene particles of known size and dose //Biomaterials. - 2000. - Vol. 21, N 20. - P. 2033-2044.
  43. McAuley J.P., Moore K.D., Culpepper W.J. et al. Total hip arthroplasty with porous-coated prostheses fixed without cement in patients who are sixty-five years of age or older //J. Bone Jt Surg. - 1998. - Vol. 80A, N 9. - P. 1648-1655.
  44. McKellop H.A., Campbell P., Park S.H. et al. The origin of submicron polyethylene wear debris in total hip arthroplasty //Clin. Orthop. - 1995. - N 311. - P. 3-20.
  45. Mundy G.R. Mechanisms of osteolytic bone destruction //Bone. - 1999. - Suppl. 1. - P. 1-16.
  46. Murray D.W., Rushton N. Macrophages stimulate bone resorbtion when they phagocytose particles //J. Bone Jt Surg. - 1990. - Vol. 72B, N 6. - P. 988-992.
  47. Nalerka J.L., Lee M.J., Kraay M.J. et al. Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis //Clin. Orthop. - 2006. - N 451. - P. 229-235.
  48. Pandey R., Quinn J.M., Sabokbar A., Athanasou N.A. Bisphosphonate inhibition of bone resorption induced by particulate biomaterial-associated macrophages //Acta Orthop. Scand. - 1996. - Vol. 67, N 2. - P. 221-228.
  49. Parfitt A.M. Targeted and non targeted bone remodeling: relationship to basic multicellular unit origination and progression //Bone. - 2002. - Vol. 30, N 1. - P. 5-7.
  50. Pokorny D., Slouf M., Horak Z. et al. Method for assessment of distribution of UHMWPE wear particles in periprosthetic tissues in total hip arthroplasty //Acta Chir. Orthop. Traumatol. Cech. - 2006. - Vol. 73, N 2. - P. 243-250.
  51. Purdue P.E., Koulouvaris P., Potter H.G. et al. The cellular and molecular biology of periprosthetic osteolysis //Clin. Orthop. - 2007. - N 454. - P. 251-261.
  52. Puri L., Wixson R.L., Stern S.H. et al. Use of helical computed tomography for the assessment of acetabular osteolysis after total hip arthroplasty //J. Bone Jt Surg. - 2002. - Vol. 84A, N 3. - P. 609-614.
  53. Revell P.A. The combined role of wear particles macrophages and lymphocytes in the loosening of total joint prostheses //http://rsif.royalsocietypublishing.org/content/
  54. Ritchlin C.T., Schwarz E.M., O'Keefe R.J., Looney R.J. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis //J. Muscoloskelet. Neuronal. Interact. - 2004. - Vol. 4, N 2. - P. 276-284.
  55. Rosanen P., Paavolainen P., Sintonen H. et al. Effectiveness of hip and knee replacement surgery in terms of quality-adjusted life years and cost //Acta Orthop. - 2007. - Vol. 78, N 1. - P. 108-115.
  56. Savarino L., Granchi D., Cenni E. et al. Systemic cross-linked N-terminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty //J. Bone Jt Surg. - 2005. - 87B, N 3. - Р. 571-576.
  57. Schmalzried T.P., Jasty M., Harris W.H. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space //J. Bone Jt Surg. - 1992. - Vol. 74A, N 6. - P. 849-863.
  58. Schwarz E.M., Lu P., Goater J. et al. TNF-α/NF-kB sig-naling in periprosthetic osteolysis //J. Orthop. Res. - 2000. - Vol. 18, N 3. - P. 472-780.
  59. Schwarz E.M., O'Keefe R.J., Looney R.J. Bone implant interface, osteolysis and potential therapies //J. Musculoskeletal Neuron Interfact. - 2004. - Vol. 4, N 4. - P. 390-392.
  60. Silva M.J., Heisel C., Schmalzried T.P. Metal-on-metal total hip replacement //Clin. Orthop. - 2005. - N 430. - P. 53-61.
  61. Simonet W.S., Lacey D.L., Dunstan C.R. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density //Cell. - 1997. - Vol. 89, N 2. - P. 309-319.
  62. Shanbhag A.S., Jacobs J.J., Black J. et al. Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty //J. Arthroplasty. - 1995. - Vol. 10, N 4. - P. 498-506.
  63. Stains J.P., Civitelli R. Cell-to-cell interactions in bone //Biochem. Biophys. Res. Commun. - 2005. - Vol. 328, N 4. - P. 721-727.
  64. Sunfeldt M., Carisson L.V., Johansson S.B. et al. Aseptic loosening, not only a question of wear //Acta Orthop. - 2006. - Vol. 77, N 2. - P. 177-197.
  65. Takagi M. Neutral proteinases and their inhibitors in the loosening of total hip prostheses //Acta Orthp. Scand. - 1996. - Vol. 67, Suppl. 271. - P. 1-29.
  66. Ulrich-Vinter M., Carmody E.E., Goater J.J. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis //J. Bone Jt Surg. - 2002. - Vol. 84A, N 8. - P. 1405-1412.
  67. Walde T.A., Weiland D.E., Leung S.B. et al. Comparison of CT, MRI, and radiographs in assessing pelvic osteolysis: a cadaveric study //Clin. Orthop. - 2005. - N 437. - P. 138-144.
  68. Wei S., Kitaura H., Zhou P. et al. IL-1 mediates TNF-induced osteoclstogenesis //J. Clin. Invest. - 2005. - Vol. 115, N 2. - P. 282-290.
  69. Wilkinson J.M., Hamer A.J., Rogers A. et al. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after hip total arthroplasty //J. Orthop. Res. - 2003. - Vol. 2003, N 4. - P. 691-696.
  70. Wilkinson J.M., Wilson A.G., Stockley I. et al. Polyethylene wear rate and osteolysis: critical threshold versus continuous dose-response relationship //J. Orthop. Res. - 2005. - Vol. 23, N 3. - P. 520-525.
  71. Willert H.G., Buchhorn G.H., Fayyazi A. et al. Metal-on metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study //J. Bone Jt Surg. - 2005. - Vol 87A, N 1. - P. 28-36.
  72. World Health Organization. The world is fast aging - have we noticed? - 2006. - http://www.who.int/ageing/en/
  73. Yamaguchi K., Masuhara K., Yamasaki S. et al. Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty //J. Orthop. Sci. - 2005. - Vol. 10, N 1. - P. 32-36.
  74. Yeung R.S.M. Bones, blood vessels and immune system: what's the link? //J. Rheumatol. - 2005. - Vol. 32, N 11. - P. 2072-2074.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-76249 от 19.07.2019.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies